Pay as you go. Fixed prices. No subscriptions
We won’t overcharge you through a subscription model. Our one off economical prices remain fixed all the time
Pay as you go. Fixed prices. No subscriptions
We won’t overcharge you through a subscription model. Our one off economical prices remain fixed all the time
Start Mounjaro weight management treatment with specialist review and ongoing support.
Body‑mass criteria:
Body‑mass criteria:
A BMI between 27 and 30 kg/m² (overweight) plus at least one weight‑related health condition, such as high blood pressure, raised cholesterol, or type 2 diabetes.
Mounjaro is intended to support meaningful, longer‑term changes alongside lifestyle measures, with the goal of improving health outcomes for people at higher risk due to excess weight.
If you meet these criteria, a clinician may decide Mounjaro is appropriate for you after a full medical assessment.
Mounjaro will be ruled out in certain situations, including if you:
Your BMI Results:
You share your health and medication history.
A clinician will check your answers and submitted photos.
We confirm if Wegovy is appropriate for you.
Check‑ins every 3 weeks to review side effects, see how your current Wegovy dose feels, and decide whether to maintain, adjusting treatment.
Mounjaro is a prescription weight loss injection used as part of a medicated weight management programme for adults living with obesity or overweight and related health conditions.
It contains tirzepatide, which acts on two gut‑hormone pathways (GIP and GLP‑1) involved in appetite, fullness and blood‑sugar control, supporting healthy weight management alongside diet and activity changes.¹ Its long half‑life allows once‑weekly dosing while maintaining these effects between doses.¹
Mounjaro is only considered where a qualified prescriber believes it is clinically appropriate after reviewing your medical history and current medicines.
Any decision to start or continue treatment is made by a qualified prescriber after medical review.
Mounjaro is used as part of medicated weight management to act on two hormone pathways, GIP and GLP‑1, that help regulate appetite, blood‑sugar control and how the body stores and uses fat.¹
Reduces appetite:
Supports insulin sensitivity:
Affects fat processing:
By acting on gut‑hormone signals, it plays a role in how your body handles fats and sugars, supporting longer‑term weight management.
Long‑acting effect:
In phase 3 trials, higher tirzepatide doses led to average body‑weight reductions of roughly 15–23%, compared with about 2–3% with placebo. ³
Many people notice changes in appetite, eating patterns and health markers over time, but Mounjaro results vary and some individuals may respond less than others.
Your clinician will review your progress regularly and may recommend adjusting, pausing or stopping treatment if it is not providing enough benefit for your healthy weight management plan.
Focused, clinician-led weight management service to support you long term and not just a quick fix. Our clinical team consists of clinicians specialised in GLP-1 treatments and are experienced in building you a tailored weight management plan.
Health coaching
Access to clinicians
Ongoing monitoring
Convenient delivery
Proven approach
It’s more than just weight loss.
Dosage
Pricing
Review
Status
2.5mg
£149
Every 3 weeks
Starting dose
5mg
£199
Every 3 weeks
First maintenance dose
7.5mg
£275
Every 3 weeks
Prescribed upon request if tolerated
10mg
£275
Every 3 weeks
Higher maintenance dose
12mg
£349
Every 3 weeks
Higher maintenance dose
15mg
£349
Every 3 weeks
Higher maintenance dose
Feature
Mounjaro (tirzepatide)
Wegovy (semaglutide)
Dosage range
2.5 mg – 15 mg once weekly, following a stepup plan set by your prescriber.
0.25 mg – 2.4 mg once weekly, following a step‑up plan set by your prescriber.
How many times a day do you take it?
Once a week
Once a week
How long can you take it for?
Long term under medical supervision, with regular reviews of benefits and side effects.
Long term under medical supervision, with regular reviews of benefits and side effects.
How it works
Suppresses appetite and reduces hunger by acting on both GIP and GLP1 hormones, which can enhance fullness and support blood sugar control.
Reduces appetite and supports weight loss by mimicking the GLP1 hormone, helping you feel fuller for longer and stabilising blood sugar levels.
Administration
Self-injectable pen used once weekly as instructed in your treatment plan.
Self-injectable pen used once weekly as instructed in your treatment plan.
Price range at WeightFall
From £149 per month for Mounjaro.
From £85 per month for Wgovy.
Suitable for
Weight loss and obesity treatment in adults who meet Mounjaro eligibility criteria (for example certain BMI thresholds and risk factors).
Weight loss and obesity treatment in adults who meet Wegovy eligibility criteria (for example certain BMI thresholds and risk factors).
How much weight can I lose?
Clinical studies show average reductions of up to around 20–23% of body weight when combined with diet and activity changes.³
Clinical studies show average reductions of around 15–20% of body weight when combined with diet and activity changes.
Mounjaro has been studied in multi‑country trials lasting up to two years, with average weight reductions of around 10–17% when combined with lifestyle changes; real‑world studies report similar patterns over six months. ¹ ²
